Comparison of the antituberculous activity of morphazinamide and pyrazinamide on chronic experimental tuberculosis. II. The emergence of resistance and its retardation in the course of monotherapy and combinations of antituberculous drugs.
D000818:Animals; D000995:Antitubercular Agents / Q000494:pharmacology*; D001391:Azo Compounds / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D066298:In Vitro Techniques; D007538:Isoniazid / Q000494:pharmacology; D051379:Mice; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D011719:Pyrazines / Q000494:pharmacology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014400:Tuberculosis, Splenic / Q000188:drug therapy*
D000995:Antitubercular Agents; D001391:Azo Compounds; D011719:Pyrazines; D007538:Isoniazid